Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights
€ 32.00 · 4.5 (283) · Auf Lager
Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?
Anesthetics Market Size, Share, Trends, Growth And Forecast Report 2024-2033
Generic Strategies
Construction Machinery Market Share, Trends And Growth Analysis Report 2033
2024 banking industry outlook
Global API Market: Crunching the Numbers - DCAT Value Chain Insights
DCAT (Drug, Chemical, & Associated Technologies Association)
DCAT Value Chain Insights (@DCATvci) / X
Neuland Labs
the Insights Value Chain. “Where AI, Machine Learning, and…, by Peter Inge
What Does the Future Hold for the Pharma Industry
)